0001654954-18-010573.txt : 20180927 0001654954-18-010573.hdr.sgml : 20180927 20180927183232 ACCESSION NUMBER: 0001654954-18-010573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180809 FILED AS OF DATE: 20180927 DATE AS OF CHANGE: 20180927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mazar Andrew Paul CENTRAL INDEX KEY: 0001727393 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55866 FILM NUMBER: 181092145 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD STREET 2: SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 5 REVERE DRIVE, SUITE 200 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: 6143958936 MAIL ADDRESS: STREET 1: 5 REVERE DRIVE, SUITE 200 CITY: NORTHBROOK STATE: IL ZIP: 60062 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2018-08-09 0001645469 Monopar Therapeutics NONE 0001727393 Mazar Andrew Paul 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 true true true Chief Scientific Officer Common stock 14002.8 D Common stock 4111272.88 I See Footnote (1) Common stock 166667 I See Footnote (2) Stock options 6 2018-08-09 4 A false 134300 0 A 2019-04-01 2028-08-08 Common stock 134300 134300 D This is based upon the 4,111,272.88 shares of Monopar Common Stock that Tactic Pharma LLC indirectly controls through TacticGem LLC. As a manager of Tactic Pharma LLC, Dr. Mazar may be deemed to share voting and dispositive power over these 4,111,272.88 shares. Dr. Mazar disclaims beneficial ownership of the 4,111,272.88 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein. This is based upon the 166,667 shares of Monopar Common Stock that Tactic Pharma LLC directly owns. As a manager of Tactic Pharma LLC, Dr. Mazar may be deemed to share voting and dispositive power over these 166,667 shares. Dr. Mazar disclaims beneficial ownership of the 166,667 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein. Stock options vest 6/51 on the six-month anniversary of vesting commencement date of October 1, 2018 and 1/51 per month thereafter. /s/ Kim R. Tsuchimoto, Attorney in fact 2018-09-27